Skip to main content
Equibles

Graham Capital Management, L.P.

Position in ALEC — Alector, Inc.

CIK 1315421 ROWAYTON, CT
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$93,456
-$70,111 QoQ
Shares Held
46,496
-55.7% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 140 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. ALEC ranks #53 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TVTX
Travere Therapeutics, Inc.
 446,696 $25,376,799
2 INCY
Incyte Corp
 15,632 $1,772,043
3 IONS
Ionis Pharmaceuticals Inc
 16,717 $1,325,490
4 VKTX
Viking Therapeutics, Inc.
 22,114 $862,667
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,256 $679,123
6 ARVN
Arvinas, Inc.
 81,364 $676,134
7 PCVX
Vaxcyte, Inc.
 11,107 $645,649
8 MRVI
Maravai Lifesciences Holdings, Inc.
 92,277 $575,808

All Filings in ALEC

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,456 46,496
2025-12-31 $163,567 104,851
2025-09-30 $62,796 21,215
2025-06-30 $29,922 21,373
2025-03-31 $50,550 41,098
2024-06-30 $61,921 13,639
2022-09-30 $431,186 45,580